| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/16/2002 | CA2162710C Dyes designed for high sensitivity detection of double-stranded dna |
| 04/16/2002 | CA2149315C Reactive and method for the detection of a nucleotide sequence with signal amplification |
| 04/16/2002 | CA2046607C Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 04/16/2002 | CA2025516C Selective leach for oxides and therein-contained metals |
| 04/12/2002 | CA2358831A1 Gene expression monitoring using universal arrays |
| 04/11/2002 | WO2002029413A2 An assay for rhabdovirus inhibitors |
| 04/11/2002 | WO2002029412A2 Selective binding materials |
| 04/11/2002 | WO2002029411A2 Magnetic in situ dilution |
| 04/11/2002 | WO2002029408A2 Methods for diagnosing and treating huntington's disease |
| 04/11/2002 | WO2002029404A1 Methods for detecting vasculopathies and tumors |
| 04/11/2002 | WO2002029402A2 System for electrophysiological measurements |
| 04/11/2002 | WO2002029379A2 Computer system for designing oligonucleotides used in biochemical methods |
| 04/11/2002 | WO2002029120A1 Method of detecting norwalk-like virus (gii) |
| 04/11/2002 | WO2002029119A1 Method of detecting norwalk-like virus (gi) |
| 04/11/2002 | WO2002029118A1 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 04/11/2002 | WO2002029117A2 Methods and probes for detection and/or quantification of nucleic acid sequences |
| 04/11/2002 | WO2002029116A2 Gene expression profiling of antidepressant action in the brain |
| 04/11/2002 | WO2002029115A1 Haplotypes of the il12a gene |
| 04/11/2002 | WO2002029114A1 Haplotypes of the ppbp gene |
| 04/11/2002 | WO2002029113A2 Methods for monitoring multiple gene expression |
| 04/11/2002 | WO2002029112A1 Renaturation, reassociation, association and hybridization of nucleic acid molecules |
| 04/11/2002 | WO2002029110A2 Efficient tests of association for quantitative traits and affected-unaffected studies using pooled dna |
| 04/11/2002 | WO2002029109A2 Multiplexed differential displacement for nucleic acid determinations |
| 04/11/2002 | WO2002029108A1 Haplotypes of the scyb14 gene |
| 04/11/2002 | WO2002029107A2 Method of detection and interpretation of mutations through expression or function tests of haploid genes |
| 04/11/2002 | WO2002029105A1 INHIBITION OF TGF-β AND USES THEREOF |
| 04/11/2002 | WO2002029104A2 Tumor marker and methods of use |
| 04/11/2002 | WO2002029103A2 Gene expression profiles in liver cancer |
| 04/11/2002 | WO2002029102A1 Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips |
| 04/11/2002 | WO2002029101A2 Methods for cloning, sequencing and expressing genes from complex microbial populations |
| 04/11/2002 | WO2002029100A1 Methods of diagnosing community acquired pneumonia (cap) and predisposition or susceptibility for cap and associated septic shock through detection of gene polymorphisms |
| 04/11/2002 | WO2002029098A2 Genetic factors affecting the outcome of viral infections |
| 04/11/2002 | WO2002029097A2 Methods relating to polymorphisms in the human gpr10 gene |
| 04/11/2002 | WO2002029096A2 Fast method for detecting organisms in a sample |
| 04/11/2002 | WO2002029095A1 Method for mutational analysis |
| 04/11/2002 | WO2002029094A2 Method of selection, by two-dimensional separation, of nucleic acids that bind to a target with high affinity |
| 04/11/2002 | WO2002029093A2 Method for selecting nucleic acids that bond with high-affinity to a target |
| 04/11/2002 | WO2002029092A2 Thermostable, photoinducible redoxactive unit for electrochemically detecting nucleic acid-oligomer hybridisation events |
| 04/11/2002 | WO2002029091A2 Methods and compositions for the treatment of inflammatory diseases |
| 04/11/2002 | WO2002029090A1 Subsance inhibiting the binding of signal transducing molecule to kdr/flk-1 phosphorylated at tyrosine at the 1175-position and method of using the same |
| 04/11/2002 | WO2002029089A2 Haplotypes of the htatip gene |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 04/11/2002 | WO2002029085A2 Nucleotide detection method |
| 04/11/2002 | WO2002029084A2 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 04/11/2002 | WO2002029083A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells |
| 04/11/2002 | WO2002029068A2 Virus-based amplification vector for plants |
| 04/11/2002 | WO2002029062A2 Cytokine proteins |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029045A2 Method for the production of vitamin k-dependent proteins |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002029035A2 Method to alter sugar moieties |
| 04/11/2002 | WO2002029025A2 Factor vii glycoforms |
| 04/11/2002 | WO2002029023A1 Nicastrin protein |
| 04/11/2002 | WO2002029015A1 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 04/11/2002 | WO2002029012A1 Processes for clonal growth of hepatic progenitor cells |
| 04/11/2002 | WO2002029007A2 Bacteria used for oxidising arsenic, method for selecting same and uses thereof for treating media containing arsenic |
| 04/11/2002 | WO2002029006A2 Methods for parallel measurement of genetic variations |
| 04/11/2002 | WO2002029005A2 Detection of ras mutations |
| 04/11/2002 | WO2002029004A2 Haplotypes of the smoh gene |
| 04/11/2002 | WO2002029003A2 Massive parallel method for decoding dna and rna |
| 04/11/2002 | WO2002028999A2 Gene expression profiles in granulocytic cells |
| 04/11/2002 | WO2002028906A2 Regulation of human sphingosine kinase-like protein |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028891A2 Listeria inocua, genome and applications |
| 04/11/2002 | WO2002028879A1 Suppressor of human breast cancer cell growth |
| 04/11/2002 | WO2002028507A2 Electronic detection of interaction based on the interruption of flow |
| 04/11/2002 | WO2002028501A1 Genotyping by liquid chromatographic analysis of short nucleic acid fragments |
| 04/11/2002 | WO2002028414A1 Compositions and methods for wt1 specific immunotherapy |
| 04/11/2002 | WO2002028410A1 Perilipin as a target for regulation of body weight, muscle mass and diabetes |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002012538A3 Nucleic acids and pathogenic e.coli proteins, and their uses |
| 04/11/2002 | WO2002012275A3 Lat peptides and their use in assays for identifying immunosuppressants |
| 04/11/2002 | WO2002006511A3 Methods for detecting and assaying nucleic acid sequences |
| 04/11/2002 | WO2002002818B1 Apparatus and method for preserving the uniqueness and identity of an individual |
| 04/11/2002 | WO2002000924A3 Viral phospholipase a2 enzymes, anti-viral agents and methods of use |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001097854A3 Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in therapeutics and/or diagnostics |
| 04/11/2002 | WO2001096592A3 Reverse detection for identification and/or quantification of nucleotide target sequences on biochips |
| 04/11/2002 | WO2001094946A9 Microarrays for performing proteomic analyses |
| 04/11/2002 | WO2001094638A8 Asynchronous primed pcr |
| 04/11/2002 | WO2001092581A8 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/11/2002 | WO2001092511A3 Purification of a triple heli formation with an immobilized oligonucleotide |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001091629A3 Methods for detecting dna damage and screening for cancer therapeutics |
| 04/11/2002 | WO2001090312A9 Ammonia-oxidizing bacteria |
| 04/11/2002 | WO2001088544A3 Proteolytic enzymes in diagnosis of kidney disorders |
| 04/11/2002 | WO2001088189A3 Microsatellite-aflp® |
| 04/11/2002 | WO2001088176A3 Measurements of enzymatic activity in a single, individual cell in population |
| 04/11/2002 | WO2001087907A3 Haplotypes of the osm gene |
| 04/11/2002 | WO2001087231A3 Methods and compositions for the diagnosis of schizophrenia |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001084146A3 A sensitive, multiplexed mass-spectrometry-based biosensor based on immuno-pcr |
| 04/11/2002 | WO2001083812A3 Method and probes for the genetic diagnosis of hemochromatosis |
| 04/11/2002 | WO2001083768A3 Serine-threonine kinase |
| 04/11/2002 | WO2001082963A3 Method of identifying and producing antigen peptides and use thereof as vaccines |